Prasanta Debnath

Consultant Gastroenterologist- Medica Superspeciality Hospital, Kolkata;
MD Internal Medicine, #UCMS&GTBH;
DM Gastroenterology @nairtnmc; DrNB Gastroenterology.

[Dr Ashish Kumar @DrAshish_Kumar]

APASL has just released its new guidelines on the management of acute variceal bleeding, led by Prof. @drshivsarin with Dr. @CosmasLesmana and Dr. @drakashshukla3 as the leading authors. I’m grateful to have been included as a co-author along with colleagues from across Asia-Pacific. These @APASLnews guidelines are published in @hepinternation1
Read full guidelines: https://t.co/fsmADIKBD2

In this thread 🧵, we share the highlights ⬇️

[Keith Siau @drkeithsiau]

PPIs are one the most commonly (and inappropriately) prescribed drug classes out there. Grateful to my colleagues for producing this state-of-the-art review paper on PPIs, covering indications, harms and a guide for deprescribing 🆕 💊⚠️

🔗: https://t.co/BrmdARqNbz

[Vishal Sharma @drvishal82]

Clinical Grand Rounds on Navigating the Differential Diagnosis of Intestinal Tuberculosis and Crohn's Disease

led by Prof Vineet Ahuja

https://t.co/KwkaNjUDep

[Juan José Chaves @juanchavesc]

My patient has swallowed a foreign body.

What do I have to do?

We will review the ESGE 2016 and ASGE 2011 Guidelines

#GITwitter #MedTwitter @ASGEendoscopy @ESGE_news

[Journal of Hepatology @JHepatology]

🆕EASL Clinical Practice Guidelines on the management of #hepatocellularcarcinoma❗️

✅Updated advice for managing patients with #HCC & comprehensive review of pertinent data

Full text👉https://t.co/IAMvBDv0CT

#CPGs
#LiverTwitter
@EASLnews
@EASLedu
@AleksanderKrag

[NEJM @NEJM]

The history and physical examination remain the cornerstone for evaluation of acute abdominal pain, but imaging methods have improved diagnostic precision and shortened the time to diagnosis. Read the full review on acute abdomen: https://t.co/6aOmn0T9b0

[John Damianos, M.D. @john_damianosMD]

A master class on prokinetics from @NGMJournal! Here is a summary! 🧵👇

⚡️🎈〽️🪠🫀💩🚄🧠✳️🗯️💊📰🚽🔌🧪💡🧲📊🔎

#MedTwitter #GITwitter #motility #pharmacology

https://t.co/KUb6K0rpIR

[Blake Burge @blakeaburge]

According to Steve Jobs, there is one single thing that "separates the people that do things from the people that just dream about them."

It isn't their intelligence, their work ethic, or their financial means.

It's something much more simple...

When Jobs was only 12 years old he opened the phone book and placed a call to Bill Hewlett (the co-founder of Hewlett-Packard).

On the call Jobs asked if Bill happened to have any spare computer parts he could have for a project he was working on––building a frequency counter.

Not only did Bill have the parts, he gave Steve a job that summer working on the assembly line at his company.

To quote Jobs, "I was in Heaven."

So what did Jobs do that was so special? (Besides calling the co-founder of a computer company when he was just 12 years old).

He asked.

Yep, that's all.

So many of us are held back by our own self-doubt or unwillingness to ask that opportunities we never even know are available pass us by.

A simple question I've used for years that has served me well:

Will I be any worse off than am I now by asking for this opportunity?

If the answer is no, which I'd argue it almost always is, ––then you've got nothing to lose.

If you're too afraid to ask, you're too afraid to fail.

And without failure, you'll never grow.

Just take action. Just ask.

If you enjoy content like this, follow me @blakeaburge for more.

[Prasanta Debnath @drprashantdn]

How to manage bleeding gastric varices due to spontaneous extrusion of previous EUS guided Nester Coil Embolization + Glue?
#gitwitter #eus #gastricvarix
#livertwitter

[Beatriz Gros @Bealoquebea]

1/ I've read the TACOS trial on the use of tofacitinib in acute severe #UC

I'll break down some important highlights &/or reflections which I found of interest
(In any case, I recommend reading the full study)

🔎Important tweets are number 7 & 8

[👩‍⚕️ Dr. Laura 👩‍⚕️ @datadriven_tdoc]

1/ As promised, and as inspired by @UofTGastroHep super⭐️ residents @youstinahanna13 and Dr. R. Khan

Is UPADACITINIB effective in the treatment of CD??

Where does UPADACITINIB fit in the treatment landscape in CD?

a new Tweetorial/X-position! (taggin' the AIBD Stars)
🧵🧵🧵

[Krishna Dharma @KrishnaDharma]

For one who has conquered the mind , the mind is the best friend. But for one who has failed to do so, his mind will remain the greatest enemy. #Bhagavadgita

[Krishna Dharma @KrishnaDharma]

Holding on to hatred is like drinking poison and hoping the other person will die.

[Paul Wischmeyer MD @Paul_Wischmeyer]

1/3-💥 12 KEY TRIALS I teach on #ICU Rounds trainees must know!

BACK by request for new residents/fellows!

❓Do you agree?

❓What others would you add?

1. ARDSNET @NEJM -PMID 10793162

2. LEUVEN Glucose 1 @NEJM-PMID 11794168

3. SAFE Trial @NEJM PMID: 15163774
#FOAMcc #MedTwitter #MedEd
#SCCMSoMe #FOAMed

[CGH @AGA_CGH]

Study finds upadacitinib therapy reduces #ulcerative colitis symptoms as early as day 1 of induction treatment. Learn more at https://t.co/AEMlsWiDJf

[Carl Kay, MD @CarlKayMD]

All 4️⃣ GI Society Guidelines in 1️⃣ Place

@AGA_Gastro 48 guidelines
@AmCollegeGastro 55 guidelines
@ASGEendoscopy 83 guidelines
@AASLDtweets 23 guidelines

Google folder:
🔗 https://t.co/moBRvEfTOS

Save this link & quickly download all PDFs

Updated as 🆕 guidelines published!

[Mark Beattie @RMBeattie50]

Check out this great new paper @FrontGastro_BMJ
Diverticular disease: update on pathophysiology, classification and management
https://t.co/xn0sgQ0ovJ
Publishing to Impact on Practice
@SophieSurgeon, @IBDdoc #Diverticulardisease
@BritSocGastro @BSPGHAN @BAPENUK @RMBeattie50

[Arslan Saleem @ArslanSaleem2]

🔥 OP Cirrhosis 🪬 by @drdina_mansour et al published in @FrontGastro_BMJ in 3️⃣ parts

@BritSocGastro @BASLedu @EASLedu

Part 1️⃣ Compensated

https://t.co/DeyzfUQ6IK

Part 2️⃣ Decompensated

https://t.co/EtDFynUUPY

Part 3️⃣ Sp circumstances

https://t.co/JrGLEXZ4Z0

[Journal of Hepatology @JHepatology]

#Anticoagulation improves survival in patients with #cirrhosis and #portalveinthrombosis

➡️The IMPORTAL competing-risk meta-analysis

Read it here👉https://t.co/V9XXYQ5Cna

@Guerrero_A_
#LiverTwitter

[Arndt Vogel @ArndtVogel]

����Hot off the press: Camrelizumab + rivoceranib vs sorafenib as 1st-line therapy for unresectable HCC: CARES-310
@TheLancet
https://t.co/chPwpOasqr
👉new interesting option
👉ORR 25%, mPFS 5.7 & mOS 22.1 mo
👉toxicity in line with MOA
👉efficacy in ALBI 1 & 2
@myESMO @EASLedu @ILCAnews #livertwitter